Big Pharma Split Corp. PRM-PA.TO Stock
9.58 CAD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Financial Services
INDUSTRY
Asset Management
COUNTRY
Canada
Exchange
Toronto
Market Cap
0 CAD
LOW - HIGH [24H]
9.53
-
9.59 CAD
VOLUME [24H]
5.7K CAD
{{ volume }}
P/E Ratio
2.93
Earnings per share
3.27 CAD
Big Pharma Split Corp. Price Chart
Big Pharma Split Corp. PRM-PA.TO Financial and Trading Overview
| Big Pharma Split Corp. stock price | 9.58 CAD |
| Previous Close | 9.95 CAD |
| Open | 10.02 CAD |
| Bid | 9.95 CAD x 0 |
| Ask | 10.53 CAD x 0 |
| Day's Range | 9.95 - 10.02 CAD |
| 52 Week Range | 9.05 - 10.78 CAD |
| Volume | 3.2K CAD |
| Avg. Volume | 484 CAD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.891774 |
| PE Ratio (TTM) | 3.047473 |
| EPS (TTM) | 3.27 CAD |
| Forward Dividend & Yield | 0.5 (5.02%) |
| Ex-Dividend Date | March 30, 2023 |
| 1y Target Est | N/A |
PRM-PA.TO Valuation Measures
| Enterprise Value | 24.13M CAD |
| Trailing P/E | 3.047473 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.7635052 |
| Enterprise Value/Revenue | 3.629 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Big Pharma Split Corp. Stock Price History
| Beta (5Y Monthly) | 0.891774 |
| 52-Week Change | -2.54% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.78 CAD |
| 52 Week Low | 9.05 CAD |
| 50-Day Moving Average | 9.74 CAD |
| 200-Day Moving Average | 9.86 CAD |
PRM-PA.TO Share Statistics
| Avg. Volume (3 month) | 484 CAD |
| Avg. Daily Volume (10-Days) | 955 CAD |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | 2.53 |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | 1.27K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.237 |
| Trailing Annual Dividend Yield | 12.43% |
| 5 Year Average Dividend Yield | 472.00% |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 35.93% |
| Operating Margin (ttm) | 86.66% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | 9.36% |
| Return on Equity (ttm) | 11.34% |
Income Statement
| Revenue (ttm) | 6.65M CAD |
| Revenue Per Share (ttm) | 4.41 CAD |
| Quarterly Revenue Growth (yoy) | -0.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | 2.39M CAD |
| Diluted EPS (ttm) | 3.265 |
| Quarterly Earnings Growth (yoy) | -79.20% |
Balance Sheet
| Total Cash (mrq) | 819.21K CAD |
| Total Cash Per Share (mrq) | 0.54 CAD |
| Total Debt (mrq) | 9.85M CAD |
| Total Debt/Equity (mrq) | 49.94 CAD |
| Current Ratio (mrq) | 0.794 |
| Book Value Per Share (mrq) | 13.032 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.13M CAD |
| Levered Free Cash Flow (ttm) | -1390256 CAD |
Profile of Big Pharma Split Corp.
| Country | Canada |
| State | ON |
| City | Oakville |
| Address | 610 Chartwell Road |
| ZIP | L6j 4A5 |
| Phone | 416-649-4541 |
| Website | https://www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/ |
| Industry | Asset Management |
| Sector(s) | Financial Services |
| Full Time Employees | N/A |
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Q&A For Big Pharma Split Corp. Stock
What is a current PRM-PA.TO stock price?
Big Pharma Split Corp. PRM-PA.TO stock price today per share is 9.58 CAD.
How to purchase Big Pharma Split Corp. stock?
You can buy PRM-PA.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Big Pharma Split Corp.?
The stock symbol or ticker of Big Pharma Split Corp. is PRM-PA.TO.
Which industry does the Big Pharma Split Corp. company belong to?
The Big Pharma Split Corp. industry is Asset Management.
How many shares does Big Pharma Split Corp. have in circulation?
The max supply of Big Pharma Split Corp. shares is 0.
What is Big Pharma Split Corp. Price to Earnings Ratio (PE Ratio)?
Big Pharma Split Corp. PE Ratio is 2.93415000 now.
What was Big Pharma Split Corp. earnings per share over the trailing 12 months (TTM)?
Big Pharma Split Corp. EPS is 3.27 CAD over the trailing 12 months.
Which sector does the Big Pharma Split Corp. company belong to?
The Big Pharma Split Corp. sector is Financial Services.